期刊文献+

米非司酮不同配伍方式对瘢痕子宫中期妊娠引产的疗效及安全性对比 被引量:1

下载PDF
导出
摘要 目的比较米非司酮不同配伍方式对瘢痕子宫中期妊娠引产的疗效及安全性。方法选取2015年12月至2019年12月在海安人民医院接受引产的90例瘢痕子宫中期妊娠女性进行回顾性分析,根据引产方法分为米非司酮+球囊组(28例)、米非司酮+米索前列醇组(32例)和米非司酮+乳酸依沙吖啶组(30例)。比较3组宫颈Bishop评分、引产效果、引产出血情况以及并发症情况。结果引产后米非司酮+乳酸依沙吖啶组显效率低于米非司酮+球囊组、米非司酮+米索前列醇组,无效率高于米非司酮+球囊组、米非司酮+米索前列醇组,差异均具有统计学意义(P<0.05),三组有效率及引产成功率差异无统计学意义(P>0.05)。3组并发症发生率差异无统计学意义(P>0.05)。结论米非司酮配伍球囊、米索前列醇及乳酸依沙吖啶在瘢痕子宫中期妊娠引产中均具有可行性,但米非司酮配伍球囊宫颈成熟程度较高、引产时间较短。
出处 《实用妇科内分泌电子杂志》 2020年第7期55-56,共2页 Electronic Journal of Practical Gynecological Endocrinology
  • 相关文献

参考文献5

二级参考文献69

  • 1周爱军,李红,程利南,王圭卿,彭献东,王宏.口服米非司酮与米索前列醇终止9~22周妊娠51例的临床观察[J].上海医科大学学报,1994,21(5):343-346. 被引量:10
  • 2Chen QJ, Hou SP, Meads C, et al. Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2011,159(2):247-254.
  • 3Ngo TD, Park MH, Xiao Y. Comparing the World Health Organization-versus China-recommended protocol for first-trimester medical abortion: a retrospective analysis[J]. lnt J Womens Health, 2012,4:123-127.
  • 4Chen MJ, Creinin MD. Mifepristone With Buecal Misoprostol for Medical Abortion: A Systematic Review[J]. Obstet Gynecol, 2015,126(1): 12-21.
  • 5Chong E, Frye LJ, Castle J, et al. A prospective, non-randonfized study of home use of mifepristone for medicm abortion in the U.S[J]. Contraception, 2015, 92(3):215-219.
  • 6Ho PC, Chan YF, Lau W. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial [J]. Contraception, 1996,53(5):281-283.
  • 7Ishikawa H, Ishi K, Serna VA, et al. Progesterone is essential for maintenance and growth of uterine leiomyoma[J]. Endocrinology, 2010,151 (6):2433-2442.
  • 8Kettel LM, Murphy AA, Morales AJ, et al. Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fihruids[J]. Hum Reprod, 1994, 9 Suppl 1: 116-120.
  • 9Kulshrestha V, Kriplani A, Agarwal N, et al. Low dose mifepristone in medical management of uterine leiomyoma: an experience from a tertiary care hospital from north India[J]. Indian J Med Res, 2013, 137(6):1154-1162.
  • 10Steinauer J, Pritts EA, Jackson R, et al. Systematic review of mifepristone for the treatment of uterine leiomyomata[J]. Obstet Gyneeol, 2004,103(6):1331-1336.

共引文献220

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部